{"nct_id":"NCT04057898","title":"Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-05-28","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["MNOV"]}